A Phase III Open, Multicentre Study to Investigate the Safety, Pharmacokinetics and Efficacy of BPL's High Purity Factor X in the Prophylaxis of Bleeding in Factor X Deficient Children Under the Age of 12 Years

Trial Profile

A Phase III Open, Multicentre Study to Investigate the Safety, Pharmacokinetics and Efficacy of BPL's High Purity Factor X in the Prophylaxis of Bleeding in Factor X Deficient Children Under the Age of 12 Years

Completed
Phase of Trial: Phase III

Latest Information Update: 12 Jul 2017

At a glance

  • Drugs Factor X (Primary)
  • Indications Factor X deficiency
  • Focus Registrational; Therapeutic Use
  • Sponsors Bio Products Laboratory
  • Most Recent Events

    • 12 Jul 2017 Results published in a Bio Products Laboratory Media Release.
    • 12 Jul 2017 According to a Bio Products Laboratory media release, data from this trial were presented at the 2017 International Society on Thrombosis and Haemostasis Congress, and published in July issue of Research and Practice in Thrombosis and Haemostasis.
    • 07 Nov 2016 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top